NM_001291867.2:c.216_218delGCC

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBA1

The NM_001291867.2(NHS):​c.216_218delGCC​(p.Pro73del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00632 in 1,071,997 control chromosomes in the GnomAD database, including 297 homozygotes. There are 1,744 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.032 ( 153 hom., 958 hem., cov: 21)
Exomes 𝑓: 0.0033 ( 144 hom. 786 hem. )

Consequence

NHS
NM_001291867.2 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.20

Publications

1 publications found
Variant links:
Genes affected
NHS (HGNC:7820): (NHS actin remodeling regulator) This gene encodes a protein containing four conserved nuclear localization signals. The encoded protein functions in eye, tooth, craniofacial and brain development, and it can regulate actin remodeling and cell morphology. Mutations in this gene have been shown to cause Nance-Horan syndrome, and also X-linked cataract-40. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2014]
NHS Gene-Disease associations (from GenCC):
  • Nance-Horan syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • early-onset nuclear cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001291867.2
BP6
Variant X-17375961-ACCG-A is Benign according to our data. Variant chrX-17375961-ACCG-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 96635.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.107 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NHSNM_001291867.2 linkc.216_218delGCC p.Pro73del disruptive_inframe_deletion Exon 1 of 9 ENST00000676302.1 NP_001278796.1 Q6T4R5-1
NHSNM_198270.4 linkc.216_218delGCC p.Pro73del disruptive_inframe_deletion Exon 1 of 8 NP_938011.1 Q6T4R5-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NHSENST00000676302.1 linkc.216_218delGCC p.Pro73del disruptive_inframe_deletion Exon 1 of 9 NM_001291867.2 ENSP00000502262.1 Q6T4R5-1
NHSENST00000380060.7 linkc.216_218delGCC p.Pro73del disruptive_inframe_deletion Exon 1 of 8 1 ENSP00000369400.3 Q6T4R5-2

Frequencies

GnomAD3 genomes
AF:
0.0324
AC:
3570
AN:
110092
Hom.:
153
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.110
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0160
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00113
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00437
Gnomad NFE
AF:
0.000343
Gnomad OTH
AF:
0.0246
GnomAD2 exomes
AF:
0.00377
AC:
186
AN:
49359
AF XY:
0.00276
show subpopulations
Gnomad AFR exome
AF:
0.110
Gnomad AMR exome
AF:
0.00690
Gnomad ASJ exome
AF:
0.000228
Gnomad EAS exome
AF:
0.00244
Gnomad FIN exome
AF:
0.000606
Gnomad NFE exome
AF:
0.000565
Gnomad OTH exome
AF:
0.00739
GnomAD4 exome
AF:
0.00333
AC:
3202
AN:
961861
Hom.:
144
AF XY:
0.00256
AC XY:
786
AN XY:
307081
show subpopulations
African (AFR)
AF:
0.121
AC:
2478
AN:
20504
American (AMR)
AF:
0.00977
AC:
190
AN:
19457
Ashkenazi Jewish (ASJ)
AF:
0.000125
AC:
2
AN:
15986
East Asian (EAS)
AF:
0.0000988
AC:
2
AN:
20244
South Asian (SAS)
AF:
0.000840
AC:
34
AN:
40491
European-Finnish (FIN)
AF:
0.000210
AC:
5
AN:
23828
Middle Eastern (MID)
AF:
0.00700
AC:
18
AN:
2571
European-Non Finnish (NFE)
AF:
0.000152
AC:
118
AN:
778856
Other (OTH)
AF:
0.00889
AC:
355
AN:
39924
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
102
204
306
408
510
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0325
AC:
3577
AN:
110136
Hom.:
153
Cov.:
21
AF XY:
0.0290
AC XY:
958
AN XY:
33006
show subpopulations
African (AFR)
AF:
0.110
AC:
3350
AN:
30363
American (AMR)
AF:
0.0159
AC:
169
AN:
10608
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2610
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3414
South Asian (SAS)
AF:
0.00113
AC:
3
AN:
2648
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5729
Middle Eastern (MID)
AF:
0.00481
AC:
1
AN:
208
European-Non Finnish (NFE)
AF:
0.000344
AC:
18
AN:
52397
Other (OTH)
AF:
0.0243
AC:
36
AN:
1484
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
112
224
337
449
561
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00694
Hom.:
38
Asia WGS
AF:
0.00592
AC:
14
AN:
2375

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Mar 03, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 26, 2014
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Mar 25, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Nance-Horan syndrome Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.2
Mutation Taster
=88/12
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10590816; hg19: chrX-17394084; API